Pushpam D - Search Results

1

Chemotherapy adaptations in a referral tertiary care center in India for ongoing therapy of pediatric patients with solid tumors during COVID19 pandemic and lockdown.

Pushpam D, Bakhshi S, Agarwala S. Pushpam D, et al. Pediatr Blood Cancer. 2020 Nov;67(11):e28428. doi: 10.1002/pbc.28428. Epub 2020 Jul 31. Pediatr Blood Cancer. 2020. PMID: 32735360 No abstract available.

2

Indicators of malnutrition in children with cancer: A study of 690 patients from a tertiary care cancer center.

Srivastava R, Pushpam D, Dhawan D, Bakhshi S. Srivastava R, et al. Among authors: pushpam d. Indian J Cancer. 2015 Apr-Jun;52(2):199-201. doi: 10.4103/0019-509X.175825. Indian J Cancer. 2015. PMID: 26853403 Free article.

3

Impact of Pediatric Malignancies on Parent's Quality of Life.

Pushpam D, Bakhshi S. Pushpam D, et al. Indian J Pediatr. 2018 Sep;85(9):713-714. doi: 10.1007/s12098-018-2735-8. Epub 2018 Jun 28. Indian J Pediatr. 2018. PMID: 29951781 Review. No abstract available.

4

Absolute Lymphocyte Count at the End of Induction as a Surrogate Marker for Minimal Residual Disease in T-cell Acute Lymphoblastic Leukemia.

Pushpam D, Chopra A, Sreenivas V, Kumar R, Bakhshi S. Pushpam D, et al. Indian Pediatr. 2019 May 15;56(5):381-383. Epub 2019 Mar 17. Indian Pediatr. 2019. PMID: 30898988 Free article. Clinical Trial.

5

Association of absolute lymphocyte count and peripheral blood lymphocyte subsets percentage with minimal residual disease at the end of induction in pediatric B cell acute lymphoblastic leukemia.

Pushpam D, Rajput N, Chopra A, Vishnubhatla S, Kumari M, Kumar R, Bakhshi S. Pushpam D, et al. Pediatr Hematol Oncol. 2019 Apr;36(3):138-150. doi: 10.1080/08880018.2019.1594469. Epub 2019 May 3. Pediatr Hematol Oncol. 2019. PMID: 31046540

6

Paediatric chronic myeloid leukaemia: Is it really a different disease?

Pushpam D, Bakhshi S. Pushpam D, et al. Indian J Med Res. 2019 May;149(5):600-609. doi: 10.4103/ijmr.IJMR_331_19. Indian J Med Res. 2019. PMID: 31417027 Free PMC article. Review.

7

Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician's perspective.

Pushpam D, Bakhshi S. Pushpam D, et al. Daru. 2020 Jun;28(1):371-385. doi: 10.1007/s40199-019-00321-z. Epub 2020 Jan 3. Daru. 2020. PMID: 31900888 Free PMC article. Review.

8

Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India.

Ganguly S, Pushpam D, Mian A, Chopra A, Gupta R, Bakhshi S. Ganguly S, et al. Among authors: pushpam d. Clin Lymphoma Myeloma Leuk. 2020 Jul;20(7):e437-e444. doi: 10.1016/j.clml.2020.02.015. Epub 2020 Mar 6. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32247650

9

Managing Pediatric Cancer Patients in COVID19 Pandemic.

Garg V, Bakhshi S, Gupta G, Pushpam D. Garg V, et al. Among authors: pushpam d. Indian J Pediatr. 2020 Jul;87(7):558. doi: 10.1007/s12098-020-03337-5. Epub 2020 May 15. Indian J Pediatr. 2020. PMID: 32415659 Free PMC article. No abstract available.

10

Predictors of Outcome in Pediatric Anaplastic Large Cell Lymphoma.

Patel A, Pushpam D, Sharma MC, Thulkar S, Bakhshi S. Patel A, et al. Among authors: pushpam d. Indian Pediatr. 2020 Jun 15;57(6):523-526. Indian Pediatr. 2020. PMID: 32562396 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters